Home/Filings/4/0001209191-19-002070
4//SEC Filing

Bodick Neil 4

Accession 0001209191-19-002070

CIK 0001419600other

Filed

Jan 3, 7:00 PM ET

Accepted

Jan 4, 5:06 PM ET

Size

6.6 KB

Accession

0001209191-19-002070

Insider Transaction Report

Form 4
Period: 2019-01-03
Bodick Neil
Chief Medical Officer
Transactions
  • Sale

    Common Stock

    2019-01-03$12.36/sh746$9,22164,782 total
Holdings
  • Common Stock

    (indirect: By Spouse)
    1,000
  • Common Stock

    (indirect: By LLC)
    388,683
Footnotes (2)
  • [F1]Sale of shares of common stock pursuant to Rule 10b5-1 arrangements to cover tax withholding obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on February 1, 2018.
  • [F2]Shares held by Versant Development Fund III, LLC. The Reporting Person is a manager and minority member of Versant Development Fund III, LLC. The Reporting Person disclaims any beneficial ownership of the shares held by Versant Development Fund III, LLC except to the extent of his pecuniary interest in these shares.

Issuer

Flexion Therapeutics Inc

CIK 0001419600

Entity typeother

Related Parties

1
  • filerCIK 0001598099

Filing Metadata

Form type
4
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 5:06 PM ET
Size
6.6 KB